Fucoidan from Undaria pinnatifida induces apoptosis in A549 human lung carcinoma cells - PubMed (original) (raw)

Fucoidan from Undaria pinnatifida induces apoptosis in A549 human lung carcinoma cells

Hye-Jin Boo et al. Phytother Res. 2011 Jul.

Abstract

Fucoidan, a sulfated polysaccharide, has various biological activities, such as anticancer, antiangiogenic and antiinflammatory effects; however, the mechanisms of action of fucoidan on anticancer activity have not been fully elucidated. The anticancer effects of fucoidan from Undaria pinnatifida on A549 human lung carcinoma cells were examined. Treatment of A549 cells with fucoidan resulted in potent antiproliferative activity. Also, some typical apoptotic characteristics, such as chromatin condensation and an increase in the population of sub-G1 hypodiploid cells, were observed. With respect to the mechanism underlying the induction of apoptosis, fucoidan reduced Bcl-2 expression, but the expression of Bax was increased in a dose-dependent manner compared with the controls. Furthermore, fucoidan induced caspase-9 activation, but decreased the level of procaspase-3. Cleavage of poly-ADP-ribose polymerase (PARP), a vital substrate of effector caspase, was found. The study further investigated the role of the MAPK and PI3K/Akt pathways with respect to the apoptotic effect of fucoidan, and showed that fucoidan activates ERK1/2 in A549 cells. Unlike ERK1/2, however, treatment with fucoidan resulted in the down-regulation of phospho-p38 expression. In addition, fucoidan resulted in the down-regulation of phospho-PI3K/Akt. Together, these results indicate that fucoidan induces apoptosis of A549 human lung cancer cells through down-regulation of p38, PI3K/Akt, and the activation of the ERK1/2 MAPK pathway.

PubMed Disclaimer

Cited by

Fucoidan's Molecular Targets: A Comprehensive Review of Its Unique and Multiple Targets Accounting for Promising Bioactivities Supported by In Silico Studies.
Zayed A, Al-Saedi DA, Mensah EO, Kanwugu ON, Adadi P, Ulber R. Zayed A, et al. Mar Drugs. 2023 Dec 30;22(1):29. doi: 10.3390/md22010029. Mar Drugs. 2023. PMID: 38248653 Free PMC article. Review.
Formulation of a thermo-sensitive hydro-gel for ulcerative colitis treatment.
Sathesh D, Sathesh Kumar K, Devadasan V, Kuppusamy S. Sathesh D, et al. Bioinformation. 2022 Oct 31;18(10):925-937. doi: 10.6026/97320630018925. eCollection 2022. Bioinformation. 2022. PMID: 37654823 Free PMC article.
Immunopotentiating Activity of Fucoidans and Relevance to Cancer Immunotherapy.
Li Y, McGowan E, Chen S, Santos J, Yin H, Lin Y. Li Y, et al. Mar Drugs. 2023 Feb 15;21(2):128. doi: 10.3390/md21020128. Mar Drugs. 2023. PMID: 36827169 Free PMC article. Review.
Seaweeds in the Oncology Arena: Anti-Cancer Potential of Fucoidan as a Drug-A Review.
Jin JO, Yadav D, Madhwani K, Puranik N, Chavda V, Song M. Jin JO, et al. Molecules. 2022 Sep 16;27(18):6032. doi: 10.3390/molecules27186032. Molecules. 2022. PMID: 36144768 Free PMC article. Review.
Impacts of Oxidative Stress and PI3K/AKT/mTOR on Metabolism and the Future Direction of Investigating Fucoidan-Modulated Metabolism.
Shiau JP, Chuang YT, Cheng YB, Tang JY, Hou MF, Yen CY, Chang HW. Shiau JP, et al. Antioxidants (Basel). 2022 May 6;11(5):911. doi: 10.3390/antiox11050911. Antioxidants (Basel). 2022. PMID: 35624775 Free PMC article. Review.

Fucoidan from Undaria pinnatifida induces apoptosis in A549 human lung carcinoma cells - PubMed (original) (raw)